Đang chuẩn bị liên kết để tải về tài liệu:
Clinical decision making in the era of immunotherapy for high grade-glioma: Report of four cases
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Immune checkpoint inhibitors (ICPIs) are being investigated in clinical trials for patients with glioblastoma. While these therapies hold great promise, management of the patients receiving such treatment can be complicated due to the challenges in recognizing immune-related adverse events caused by checkpoint inhibitor treatment. | Clinical decision making in the era of immunotherapy for high grade-glioma Report of four cases